Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial

by Vibeke Strand, Sophie Dimonaco, Katie Tuckwell, Micki Klearman, Neil Collinson, John H. Stone
Published 2019-02-01

Development and Implementation of a Double-Blind Corticosteroid-Tapering Regimen for a Clinical Trial

by Neil Collinson, Katie Tuckwell, Frank Habeck, Monique Chapman, Micki Klearman, John H. Stone
Published 2015-01-01

Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumab

by Katie Tuckwell, Cem Gabay, Thierry Sornasse, Ruediger Paul Laubender, Jianmei Wang, Michael J. Townsend
Published 2019-12-01

Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data

by Sara Gale, Huong Trinh, Katie Tuckwell, Neil Collinson, John H. Stone, Khaled Sarsour, Jinglan Pei, Jennie Best, Christine Birchwood, Shalini V. Mohan
Published 2019-02-01